Compounds > carvedilol
Page last updated: 2024-10-24

carvedilol and Carditis

carvedilol has been researched along with Carditis in 24 studies

Research Excerpts

ExcerptRelevanceReference
"Carvedilol in 3 doses (2, 10, and 30 mg/kg) was given daily to 3 study groups of rats (n = 8) with experimental autoimmune myocarditis by gastric gavage for 3 weeks."7.88Carvedilol Inhibits Matrix Metalloproteinase-2 Activation in Experimental Autoimmune Myocarditis: Possibilities of Cardioprotective Application. ( Biczysko, W; Ceremuga, I; Dziegiel, P; Haczkiewicz, K; Kobierzycki, C; Kwiatkowska, J; Piasecki, T; Podhorska-Okolow, M; Sapa, A; Skrzypiec-Spring, M; Szelag, A; Wozniak, M, 2018)
"This study aims to compare the effects of carvedilol and metoprolol in alleviating viral myocarditis (VMC) induced by coxsackievirus B3 (CVB3) in mice."7.80Carvedilol has stronger anti-inflammation and anti-virus effects than metoprolol in murine model with coxsackievirus B3-induced viral myocarditis. ( Chen, C; Chen, Q; Chen, Y; Chu, M; Jiang, J; Pan, L; Qian, Y; Wang, D; Zhou, A, 2014)
"This study was therefore designed to examine the effects of carvedilol on the transcriptional factor CREB in a murine model of acute viral myocarditis."7.79Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis. ( Li-Sha, G; Na-Dan, Z; Teng, Z; Yi-He, C; Yue-Chun, L, 2013)
"The study was designed to compare the effects of ivabradine and carvedilol in acute viral myocarditis."7.78Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis. ( Jia-Feng, L; Li-Sha, G; Na-Dan, Z; Qin, L; Teng, Z; Xue-Qiang, G; Yue-Chun, L, 2012)
"To observe the effects of carvedilol on the expression of Bcl-2, Bax and Fas in autoimmune myocarditis (AM)."7.77[Effects of carvedilol on cardiomyocyte apoptosis in autoimmune myocarditis in mice]. ( Chen, Q; Jiang, JB; Qiu, HX; Rong, X; Wang, ZQ; Wu, HP; Wu, RZ; Xiang, RL, 2011)
"The cardioprotective effects of carvedilol were studied in a rat model of experimental autoimmune myocarditis (EAM)."7.76Immunoregulatory effects of carvedilol on rat experimental autoimmune myocarditis. ( Chen, L; Gu, W; Kong, Y; Li, W; Liu, H; Yang, N, 2010)
"Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis."7.74Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008)
"In a coxsackievirus B3 murine myocarditis model (BALB/c), effects of carvedilol and metoprolol on myocardial cytokine expression, inflammatory cell infiltration and MMP/TIMP profiles were investigated."7.73Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. ( Chandrasekharan, K; Li, J; Noutsias, M; Pauschinger, M; Peter Schwimmbeck, L; Poller, W; Rutschow, S; Schultheiss, HP; Tschope, C; Weitz, A; Westermann, D; Zeichhardt, H, 2005)
"This study was designed to examine the effects of carvedilol in a murine model of viral myocarditis induced by encephalomyocarditis virus (EMCV) infection."7.72Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. ( Matsumori, A; Nishio, R; Sasayama, S; Shioi, T, 2003)
"We investigated whether carvedilol protects against experimental autoimmune myocarditis (EAM) attributing to antioxidant properties."7.72Cardioprotective effects of carvedilol on acute autoimmune myocarditis. ( Kishimoto, C; Nimata, M; Shioji, K; Yuan, Z, 2004)
"Carvedilol, a vasodilating nonselective beta-adrenoceptor antagonist, but not metoprolol, a selective beta1-adrenoceptor antagonist, has been shown to increase the production of cardiac antiinflammatory cytokines in experimental myocarditis."7.72Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol. ( Noutsias, M; Pauschinger, M; Rutschow, S; Schultheiss, HP; Schwimmbeck, PL; Steendijk, P; Tschöpe, C; Weitz, A; Westermann, D, 2004)
"Carvedilol is a nonselective β-blocker with α1-adrenergic blocking and antioxidant properties."6.48The mechanism of carvedilol in experimental viral myocarditis. ( Jia-Feng, L; Li-Sha, G; Xue-Qiang, G; Yue-Chun, L, 2012)
"Carvedilol in 3 doses (2, 10, and 30 mg/kg) was given daily to 3 study groups of rats (n = 8) with experimental autoimmune myocarditis by gastric gavage for 3 weeks."3.88Carvedilol Inhibits Matrix Metalloproteinase-2 Activation in Experimental Autoimmune Myocarditis: Possibilities of Cardioprotective Application. ( Biczysko, W; Ceremuga, I; Dziegiel, P; Haczkiewicz, K; Kobierzycki, C; Kwiatkowska, J; Piasecki, T; Podhorska-Okolow, M; Sapa, A; Skrzypiec-Spring, M; Szelag, A; Wozniak, M, 2018)
"This study was therefore designed to examine the effects of carvedilol on the transcriptional factor CREB in a murine model of acute viral myocarditis."3.79Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis. ( Li-Sha, G; Na-Dan, Z; Teng, Z; Yi-He, C; Yue-Chun, L, 2013)
"The study was designed to compare the effects of ivabradine and carvedilol in acute viral myocarditis."3.78Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis. ( Jia-Feng, L; Li-Sha, G; Na-Dan, Z; Qin, L; Teng, Z; Xue-Qiang, G; Yue-Chun, L, 2012)
"To observe the effects of carvedilol on the expression of Bcl-2, Bax and Fas in autoimmune myocarditis (AM)."3.77[Effects of carvedilol on cardiomyocyte apoptosis in autoimmune myocarditis in mice]. ( Chen, Q; Jiang, JB; Qiu, HX; Rong, X; Wang, ZQ; Wu, HP; Wu, RZ; Xiang, RL, 2011)
"The cardioprotective effects of carvedilol were studied in a rat model of experimental autoimmune myocarditis (EAM)."3.76Immunoregulatory effects of carvedilol on rat experimental autoimmune myocarditis. ( Chen, L; Gu, W; Kong, Y; Li, W; Liu, H; Yang, N, 2010)
"Carvedilol, a nonselective beta-blocker with additional alpha1-adrenergic blocking and antioxidant properties, has been shown to be cardioprotective in experimental myocarditis."3.74Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis. ( Ji-Fei, T; Jia-Feng, L; Jiang-Hua, R; Li-Sha, G; Peng, C; Peng-Lin, Y; Yue-Chun, L; Zhan-Qiu, Y, 2008)
"In a coxsackievirus B3 murine myocarditis model (BALB/c), effects of carvedilol and metoprolol on myocardial cytokine expression, inflammatory cell infiltration and MMP/TIMP profiles were investigated."3.73Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response. ( Chandrasekharan, K; Li, J; Noutsias, M; Pauschinger, M; Peter Schwimmbeck, L; Poller, W; Rutschow, S; Schultheiss, HP; Tschope, C; Weitz, A; Westermann, D; Zeichhardt, H, 2005)
"This study was designed to examine the effects of carvedilol in a murine model of viral myocarditis induced by encephalomyocarditis virus (EMCV) infection."3.72Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. ( Matsumori, A; Nishio, R; Sasayama, S; Shioi, T, 2003)
"We investigated whether carvedilol protects against experimental autoimmune myocarditis (EAM) attributing to antioxidant properties."3.72Cardioprotective effects of carvedilol on acute autoimmune myocarditis. ( Kishimoto, C; Nimata, M; Shioji, K; Yuan, Z, 2004)
"Carvedilol, a vasodilating nonselective beta-adrenoceptor antagonist, but not metoprolol, a selective beta1-adrenoceptor antagonist, has been shown to increase the production of cardiac antiinflammatory cytokines in experimental myocarditis."3.72Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol. ( Noutsias, M; Pauschinger, M; Rutschow, S; Schultheiss, HP; Schwimmbeck, PL; Steendijk, P; Tschöpe, C; Weitz, A; Westermann, D, 2004)
" The cardioprotective properties of carvedilol, a vasodilating beta-adrenoceptor-blocking agent, were studied in a rat model of dilated cardiomyopathy after autoimmune myocarditis."3.71Effects of carvedilol on cardiac function and cardiac adrenergic neuronal damage in rats with dilated cardiomyopathy. ( Aizawa, Y; Ashino, H; Fuse, K; Kodama, M; Nakazawa, M; Takahashi, T; Tanabe, N; Tazawa, S; Wahed, MI; Watanabe, K, 2002)
"The cardioprotective properties of carvedilol (a vasodilating beta-adrenoceptor blocking agent) were studied in a rat model of dilated cardiomyopathy induced by autoimmune myocarditis."3.70Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy. ( Aizawa, Y; Fuse, K; Hanawa, H; Hasegawa, G; Higuchi, H; Hirono, S; Ito, M; Kato, K; Kodama, M; Naito, M; Nakazawa, M; Ohta, Y; Tanabe, N; Watanabe, K, 2000)
"Carvedilol is a nonselective β-blocker with α1-adrenergic blocking and antioxidant properties."2.48The mechanism of carvedilol in experimental viral myocarditis. ( Jia-Feng, L; Li-Sha, G; Xue-Qiang, G; Yue-Chun, L, 2012)

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (41.67)29.6817
2010's14 (58.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Zijll Langhout, M1
Wolters, M1
Horvath, KM1
Thiesbrummel, H1
Smits, P1
van Bolhuis, H1
van der Hulst, V1
Riezebos, R1
Skrzypiec-Spring, M1
Haczkiewicz, K1
Sapa, A1
Piasecki, T1
Kwiatkowska, J1
Ceremuga, I1
Wozniak, M1
Biczysko, W1
Kobierzycki, C1
Dziegiel, P1
Podhorska-Okolow, M1
Szelag, A1
Guang-Yi, C1
Li-Sha, G5
Yue-Chun, L5
Yi-He, C1
Na-Dan, Z2
Teng, Z2
Wang, D1
Chen, Y1
Jiang, J1
Zhou, A1
Pan, L1
Chen, Q2
Qian, Y1
Chu, M1
Chen, C1
Teoh, JP1
Park, KM1
Broskova, Z1
Jimenez, FR1
Bayoumi, AS1
Archer, K1
Su, H1
Johnson, J1
Weintraub, NL1
Tang, Y1
Kim, IM1
Liu, H1
Li, W1
Gu, W1
Kong, Y1
Yang, N1
Chen, L1
Pergola, G1
Cascone, A1
Russo, M1
Li, YC2
Ge, LS2
Yang, PL1
Tang, JF1
Lin, JF2
Chen, P1
Guan, XQ2
Dabrowski, R1
Pedzich-Placha, E1
Wu, RZ1
Wu, HP1
Wang, ZQ1
Rong, X1
Jiang, JB1
Qiu, HX1
Xiang, RL1
Xue-Qiang, G2
Jia-Feng, L3
Qin, L1
Luo, Q1
Chen, YH1
Zhou, ND1
Zhang, T1
Nishio, R1
Shioi, T1
Sasayama, S1
Matsumori, A1
Yuan, Z2
Shioji, K2
Kihara, Y1
Takenaka, H1
Onozawa, Y1
Kishimoto, C2
Nimata, M1
Tschöpe, C2
Westermann, D2
Steendijk, P1
Noutsias, M2
Rutschow, S2
Weitz, A2
Schwimmbeck, PL1
Schultheiss, HP2
Pauschinger, M2
Chandrasekharan, K1
Peter Schwimmbeck, L1
Zeichhardt, H1
Poller, W1
Li, J1
Jiang-Hua, R1
Peng-Lin, Y1
Ji-Fei, T1
Peng, C1
Zhan-Qiu, Y1
Fett, JD1
Watanabe, K2
Ohta, Y1
Nakazawa, M2
Higuchi, H1
Hasegawa, G1
Naito, M1
Fuse, K2
Ito, M1
Hirono, S1
Tanabe, N2
Hanawa, H1
Kato, K1
Kodama, M2
Aizawa, Y2
Takahashi, T1
Wahed, MI1
Ashino, H1
Tazawa, S1
Merlet, P1
Hittinger, L1
Dubois-Randé, JL1
Castaigne, A1

Reviews

2 reviews available for carvedilol and Carditis

ArticleYear
Role of Heart Rate Reduction in the Management of Myocarditis.
    Current pharmaceutical design, 2018, Volume: 24, Issue:3

    Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; Carvedilol; Heart Rate; Humans; Inflamm

2018
The mechanism of carvedilol in experimental viral myocarditis.
    Current pharmaceutical design, 2012, Volume: 18, Issue:12

    Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Disease Models, Animal; Mice; Myocardi

2012

Other Studies

22 other studies available for carvedilol and Carditis

ArticleYear
Clinical signs, diagnostics and successful treatment of a myocarditis in an adult chimpanzee (Pan troglodytes).
    Journal of medical primatology, 2017, Volume: 46, Issue:5

    Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Ape Diseases; Carbazoles; Carvedilol;

2017
Carvedilol Inhibits Matrix Metalloproteinase-2 Activation in Experimental Autoimmune Myocarditis: Possibilities of Cardioprotective Application.
    Journal of cardiovascular pharmacology and therapeutics, 2018, Volume: 23, Issue:1

    Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Autoimmune Diseases; Carbazoles; Carvedilol; Di

2018
Effects of carvedilol treatment on cardiac cAMP response element binding protein expression and phosphorylation in acute coxsackievirus B3-induced myocarditis.
    BMC cardiovascular disorders, 2013, Nov-14, Volume: 13

    Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Coxsackievirus Infectio

2013
Carvedilol has stronger anti-inflammation and anti-virus effects than metoprolol in murine model with coxsackievirus B3-induced viral myocarditis.
    Gene, 2014, Sep-01, Volume: 547, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Carbazoles; Carvedilol; Cytokines; Enterovirus B, Human; Metoprolol

2014
Identification of gene signatures regulated by carvedilol in mouse heart.
    Physiological genomics, 2015, Volume: 47, Issue:9

    Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Cardiomyopathies; Carvedilol; Gene Expression Regu

2015
Immunoregulatory effects of carvedilol on rat experimental autoimmune myocarditis.
    Scandinavian journal of immunology, 2010, Volume: 71, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Atrial Natriuretic Factor; Autoi

2010
Acute pericarditis and myocarditis by Toxoplasma gondii in an immunocompetent young man: a case report.
    Le infezioni in medicina, 2010, Volume: 18, Issue:1

    Topics: Acute Disease; Adult; Aluminum Hydroxide; Antibodies, Protozoan; Carbazoles; Carvedilol; Chest Pain;

2010
Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.
    European journal of pharmacology, 2010, Aug-25, Volume: 640, Issue:1-3

    Topics: Adrenergic Antagonists; Aldehydes; Animals; Body Weight; Carbazoles; Carvedilol; Electrocardiography

2010
[Improvement of left ventricular function during combined carvedilol, ramipril and spironolactone therapy after myocarditis in patient treated earlier by chemotherapy due to Hodgkin's lymphoma - 3-years follow-up].
    Kardiologia polska, 2010, Volume: 68, Issue:7

    Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Carbazoles; Carvedilol

2010
[Effects of carvedilol on cardiomyocyte apoptosis in autoimmune myocarditis in mice].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2011, Volume: 49, Issue:5

    Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Autoimmune Diseases; bcl-2-Associated X Protein; Ca

2011
Comparison of effects of ivabradine versus carvedilol in murine model with the Coxsackievirus B3-induced viral myocarditis.
    PloS one, 2012, Volume: 7, Issue:6

    Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Benzazepines; Carbazoles; Carvedilol; Coxsackieviru

2012
Ivabradine inhibits the production of proinflammatory cytokines and inducible nitric oxide synthase in acute coxsackievirus B3-induced myocarditis.
    Biochemical and biophysical research communications, 2013, Feb-15, Volume: 431, Issue:3

    Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Benzazepines; Carbazoles; Carvedilol; Coxsackievir

2013
Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus.
    Journal of the American College of Cardiology, 2003, Jan-15, Volume: 41, Issue:2

    Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Cardiovirus Infections; Carvedilol; Dose-Response

2003
Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
    American journal of physiology. Heart and circulatory physiology, 2004, Volume: 286, Issue:1

    Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Autoimm

2004
Cardioprotective effects of carvedilol on acute autoimmune myocarditis.
    Molecular and cellular biochemistry, 2004, Volume: 259, Issue:1-2

    Topics: Administration, Oral; Animals; Autoimmune Diseases; Carbazoles; Cardiotonic Agents; Carvedilol; Dose

2004
Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol.
    European journal of pharmacology, 2004, May-03, Volume: 491, Issue:2-3

    Topics: Animals; Carbazoles; Carvedilol; Coxsackievirus Infections; Male; Metoprolol; Mice; Mice, Inbred BAL

2004
Carvedilol improves left ventricular function in murine coxsackievirus-induced acute myocarditis association with reduced myocardial interleukin-1beta and MMP-8 expression and a modulated immune response.
    European journal of heart failure, 2005, Volume: 7, Issue:4

    Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Coxsackievirus Infections; Interleukin

2005
Protective effects of carvedilol in murine model with the coxsackievirus B3-induced viral myocarditis.
    Journal of cardiovascular pharmacology, 2008, Volume: 51, Issue:1

    Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Anti-Inflammatory Agents; Antioxidants; Carbazo

2008
Case 36-2007: a woman with rash, fever, and hypotension.
    The New England journal of medicine, 2008, Mar-27, Volume: 358, Issue:13

    Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Carbazoles; Carvedilol; Female; Humans; Hypotensi

2008
Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy.
    British journal of pharmacology, 2000, Volume: 130, Issue:7

    Topics: Animals; Body Weight; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Disease Progression; Endomyoc

2000
Effects of carvedilol on cardiac function and cardiac adrenergic neuronal damage in rats with dilated cardiomyopathy.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:4

    Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adrenergic Fibers; Animals; Autoimmune Diseases;

2002
Myocardial adrenergic dysinnervation in dilated cardiomyopathy: cornerstone or epiphenomenon?
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2002, Volume: 43, Issue:4

    Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Adrenergic Fibers; Animals; Carbazoles; Cardiomy

2002